Accelus Announces Closing of $20 Million Debt Facility with Symbiotic Capital
January 18, 2024 08:15 ET
|
Accelus
Accelus has announced the closing of a $20 million debt facility with Symbiotic Capital.
Accelus Announces Renewed Focus on Pioneering Minimally Invasive Outpatient Procedures with Its Advanced Adaptive Geometry Technology
December 07, 2023 08:23 ET
|
Accelus
Accelus announces a renewed focus on MIS with its innovative FlareHawk system for outpatient and awake lumbar fusion, aligning with 2024 trends.
Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System
May 19, 2022 08:35 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 19, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Safe and Efficacious Treatment of Spondylolisthesis via MIS TLIF Approach with the FlareHawk® Expandable Cage
December 01, 2020 08:00 ET
|
Integrity Implants Inc.
PALM BEACH GARDENS, Fla., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Integrity Implants Inc., a privately held medical device company dedicated to delivering innovative solutions for spine surgery, today...
Clinical Evidence Shows that the FlareHawk® Multiplanar Expandable Cage Delivers Favorable Fusion and Patient Outcomes Demonstrating Conformity to Endplate Anatomy with No Observed Device Subsidence
November 12, 2020 08:00 ET
|
Integrity Implants Inc.
PALM BEACH GARDENS, Fla., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Integrity Implants Inc., a privately held medical device company dedicated to delivering innovative solutions for spine surgery, today...
Clinical Study Demonstrates Favorable Patient Outcomes with the FlareHawk® Expandable Cage
March 03, 2020 08:00 ET
|
Integrity Implants Inc.
PALM BEACH GARDENS, Fla., March 03, 2020 (GLOBE NEWSWIRE) -- Integrity Implants Inc., a privately held medical device company dedicated to delivering innovative solutions for spine surgery, today...